CSIMarket Company Name, Ticker, Customers, else..
 
Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 
 
Price: $5.8200 $0.00 0.000%
Day's High: $5.9199 Week Perf: 2.11 %
Day's Low: $ 5.58 30 Day Perf: -18.83 %
Volume (M): 32 52 Wk High: $ 8.48
Volume (M$): $ 185 52 Wk Avg: $5.08
Open: $5.66 52 Wk Low: $2.05



 Market Capitalization (Millions $) 78
 Shares Outstanding (Millions) 13
 Employees -
 Revenues (TTM) (Millions $) 34
 Net Income (TTM) (Millions $) -26
 Cash Flow (TTM) (Millions $) -30
 Capital Exp. (TTM) (Millions $) 2

Casi Pharmaceuticals Inc
Casi Pharmaceuticals Inc. is a pharmaceutical company that focuses on the acquisition, development, and commercialization of drugs for the treatment of various types of cancer and other diseases. The company primarily focuses on the Chinese market and has a strong presence in China's healthcare system. Casi Pharmaceuticals has a diverse pipeline of drug candidates in various stages of development and collaborates with other companies and research institutions to advance its drug portfolio. The company is committed to bringing innovative therapies to patients and improving their quality of life.


   Company Address: 1701-1702, China Central Office Tower 1 Beijing 100025 MD
   Company Phone Number: 864-2600   Stock Exchange / Ticker: NASDAQ CASI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Stocks on the Move

Casi Pharmaceuticals Incs Shares Soar Above Market Average Amidst Positive Developments

Published Mon, Jul 22 2024 7:06 PM UTC

In recent weeks, Casi Pharmaceuticals Inc has gained significant traction in the market, outperforming the general market trend with a 2.09% increase in share prices. This surge can be attributed to several positive developments, including noteworthy updates on their ongoing disputes with Juventas, a Cayman-incorporated biopharmaceutical company. Casi Pharmaceuticals, Inc. (...
Stocks on the Move

Casi Pharmaceuticals Inc Examining the Recent Sell-off and Key Market Events

Published Wed, Jul 10 2024 6:19 PM UTC

Casi Pharmaceuticals Inc has been outperforming the market, with its shares experiencing a 1.72% performance boost during the current month. However, a recent sell-off has caught the attention of investors and industry experts alike. In this article, we will delve into the events surrounding the sell-off and analyze its potential impact on Casi Pharmaceuticals Inc.Health & P...
Stocks on the Move

CASI Pharmaceuticals Inc Pioneering New Frontiers in Biopharmaceuticals

Published Fri, Jul 5 2024 6:53 PM UTC

CASI Pharmaceuticals Inc has recently been in the limelight, with a series of significant developments unfolding in a short span of time. This article delves into the recent articles surrounding CASI Pharmaceuticals and assesses their impact on the company's performance in the biopharmaceutical industry. Analysis:1. Is CASI Pharmaceuticals Inc (CASI) Stock Paving the Way for...
Casi Pharmaceuticals Inc

Casi Pharmaceuticals Inc. Faces Major Setback with -21.41% Revenue Decline in Fourth Quarter of 2023

Casi Pharmaceuticals Inc. is a biopharmaceutical company that is dedicated to developing and commercializing innovative therapeutics and pharmaceutical products. The company recently reported its financial results for the fiscal three months ending December 31, 2023, which showed a decline in business and an increase in deficit. This has caused concern among investors and stakeholders as the company continues to face challenges in the market.
During this fiscal quarter, Casi Pharmaceuticals Inc.'s deficit per share increased to $-2.02 from $-3.01, while revenue declined by -21.41% to $33.88 million from $43.11 million in the previous year. The company also reported a net deficit of $-26.259 million, compared to a deficit of $-40.257 million in the same quarter a year ago. These financial results paint a bleak picture for the company's performance in the current market.






Casi Pharmaceuticals Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com